TMパートナーズ合同会社

TMパートナーズ合同会社

Multifunctional support for businesses in the healthcare field

Over 30 years of multifaceted experience in R&D, operations, management, and human resource development of pharmaceuticals and medical devices in various Japanese and international organizations (academia, business companies, investment companies, and local governments)

  • Experienced in academia drug discovery research and licensing that resulted patents in the U.S.
  • Experienced in drug discovery research, launching a new business, and business development within a pharmaceutical company
  • Hands-on investment in listed Japanese biotech companies
  • Invested in Japanese and European biotech ventures as a venture capitalist
  • Participation in corporate management as an External Director and Chair of Audit and Supervisory Committee

Past Projects

Providing a variety of services tailored to client needs

Advice on critical issues facing business functions

  • Advice on general business operations
  • Advice on research and development activities
  • Support for commercialization of technologies and drug discovery in academia

Advice on business development

  • Support for business development and licensing
  • Advice on business alliances and M&A schemes

Advice on investment projects

  • Evaluation of new investment opportunities
  • Due diligence of new investment opportunities
  • Advice on existing portfolio companies

Human resource development

  • Counseling for CEOs
  • Training for human resource development (Japanese and English)
    • Training for global leaders and leadership training for the new era
    • New business creation and value maximization

Overview

Message from the CEO

The operational rationale of TM Partners:
I would like to reflect on what I value in my work. As a student, I was trained in the fundamentals of research by a professor who was passionate about education. In my third year of the doctoral program, I was exposed to drug discovery research as an intern at a U.S. research institute of a global pharmaceutical company. After obtaining a Ph.D. in Pharmaceutical Sciences, I spent 11 years as a member of the U.S. National Cancer Institute, where I experienced the excitement and rigors of research and development in an intensely competitive environment. During this time, I experienced drug discovery in academia, successfully out-licensed two biopharmaceutical candidates of which I was involved in the research and development, and learned American-style management and human resource development.

I then joined a Japanese pharmaceutical company, where I gained valuable business experience not only as a research leader in antibody drugs, but also in launching new businesses in the U.S., exploring and evaluating new external technologies and pipelines, and in business development. After that, I had the opportunity to move to an investment company that made hands-on investments in listed Japanese biotech companies, where I came to various realizations. I founded TM Partners LLC with the desire to assist in the research and development of academia drug discovery and venture companies in Japan, as well as in the management and human resource development of the new era.

My creed is to “save as many patients as possible as soon as possible” when accepting professional challenges. From an objective standpoint, I consider whether the client's research and development is truly being conducted in the most optimal manner, whether the organization is being managed appropriately. TM Partners is committed to helping realize an affluent society with wellbeing by providing “multifunctional support for businesses in the healthcare field.”

October 1, 2024
Toshiyuki Mori

Toshiyuki Mori

Company Information

Company Name TM Partners LLC
CEO Toshiyuki Mori, Ph.D.
Year of establishment 2018

Biography

  • 1990

    Passed the national pharmacist exam

  • 1992 ~
    1995

    Research Fellowship for Young Scientists, Japan Society for the Promotion of Science

  • 1995

    Intern, Hoffman La Roche (NJ, USA)

  • 1995

    Completed doctoral course at Hokkaido University Graduate School of Pharmaceutical Sciences and obtained a Ph.D. in Pharmaceutical Sciences.

  • 1995 ~
    2005

    Worked primarily in biopharmaceutical and infectious disease research at the U.S. National Cancer Institute for 11 years. Two substances, including one discovered by myself, have entered clinical trials with clinical trials still ongoing.

  • 2005 ~
    2014

    At Takeda Pharmaceutical Company Limited, while leading the team for pharmacological evaluation of antibody drugs, I was involved in the business strategy of antibody drug R&D. I was also in charge of directing the launch of the antibody research institute in the U.S., conducting external technology evaluations of all disease areas and platform technologies, contract negotiations/conclusion and alliance management. In addition, participating in multiple company-wide projects on behalf of the department.

  • 2014 ~
    2018

    Joined an independent investment firm which invested in and provided direct support to biotech venture companies listed in Japan, and also helped commercialize the research results of multiple academic institutions.

  • 2018 ~

    Founded TM Partners, LLC, which provides consulting services to academia, biotech companies, venture capitals, and business corporations. I have also been involved in human resource development training for major pharmaceutical companies and counseling for CEOs. As part of business, I became an investment partner of a European venture capital firm for two years from October 2018, investing in unlisted companies in Japan and Europe in the areas of drug discovery and medical devices.

    Peer review papers: 45; Patents granted in the United States: 5

Current main position

  • 2019 ~

    External Director, Edit Force, Inc.

  • 2019 ~

    Evaluation Committee Member, Japan Agency for Medical Research and Development (AMED)

  • 2020 ~

    Deputy Director, Toyama Pharmaceutical Vally Development Consortium, Toyama Prefecture Gov.

  • 2020 ~

    External Director and Chair of Audit and Supervisory Committee, J-Pharma Co., Ltd.

  • 2022 ~

    Startup Strategy Committee Member, Toyama Prefecture Gov.

  • 2023 ~

    Expert Committee Member, JST “University-originated new industry creation fund project feasibility verification”

Contact

Please contact me on FB or LinkedIn